Alentis Therapeutics Expands Leadership Team with the Appointment of Rizwan Velji as Chief Business Officer
Velji brings more than 20 years of experience in biotech financial services December 06, 2023 08:00 AM Eastern Standard Time BASEL, Switzerland–(BUSINESS WIRE)–Alentis Therapeutics (“Alentis”), a clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis, today announced that Rizwan Velji has been appointed Chief Business Officer (CBO). He will lead corporate strategy, business development, and finance. Rizwan Velji, Chief Business Officer … Continue reading Alentis Therapeutics Expands Leadership Team with the Appointment of Rizwan Velji as Chief Business Officer